Stock Screener App

Frei -

Installieren

1.97

3.14% 0.06

Inhibikase Therapeutics Inc (IKT)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Finanzdaten der Inhibikase Therapeutics Inc-Aktie (IKT)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Selling, General, and Administrative	3.82% 7.6575	7.3761	6.7746	5.6115	5.9197
Costs And Expenses	17.99% 21.05	17.84	13.78	12.77	10.83
Operating Income/Loss	17.99% -21.05	-17.84	-13.78	-12.77	-10.83
Net Interest Income/Expense	0.09% 1.4598	1.4611	1.041	0.8381	0.9168
Income Tax Expense/Benefit	-	-	-	-	-
Net Income/Loss	19.60% -19.59	-16.38	-12.73	-11.93	-9.9155
Basic Average Shares	1.31% 174.57	172.31	-	90.05	90.01
Diluted Average Shares	1.31% 174.57	172.31	-	90.05	90.01
Basic Earnings Per Share	10.00% -0.11	-0.10	-	-0.13	-0.11
Diluted Earnings Per Share	10.00% -0.11	-0.10	-	-0.13	-0.11

FTH

$26.03

1.64%

ZVRA

$11.39

3.55%

AURA

$6.54

0.54%

MDXG

$4.67

1.08%

WVE

$3.46

0.29%

OLMA

$7.82

0.00%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters